{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:47:10Z","timestamp":1793389630317,"version":"4.5.0"},"reference-count":189,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,31]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Peripheral T-cell lymphomas (PTCLs) encompass a heterogeneous group of postthymic T-cell lymphomas with &amp;gt;30 distinct subtypes associated with varied clinicopathological features. Unfortunately, the overall survival of the major PTCL subtypes is dismal and has not improved for decades; thus, there is an urgent unmet clinical need to improve diagnosis, therapies, and clinical outcomes. The diagnosis is often challenging, requiring a combinatorial evaluation of clinical, morphologic, and immunophenotypic features. PTCL pathobiology is difficult to investigate due to enormous intertumor and intratumor heterogeneity, limited tissue availability, and the paucity of authentic T-cell lymphoma cell lines or genetically faithful animal models. The application of transcriptomic profiling and genomic sequencing has markedly accelerated the discovery of new biomarkers, molecular signatures, and genetic lesions, and some of the discoveries have been included in the revised World Health Organization or International Consensus Classification. Genome-wide investigations have revealed the mutational landscape and transcriptomic profiles of PTCL entities, defined the cell of origin as a major determinant of T-cell lymphoma biology, and allowed for the refinement of biologically and clinically meaningful entities for precision therapy. In this review, we prioritize the discussion on common nodal PTCL subtypes together with 2 virus-associated T-cell and natural killer cell lymphomas. We succinctly review normal T-cell development, differentiation, and T-cell receptor signaling as they relate to PTCL pathogenesis and biology. This review will facilitate a better biological understanding of the different PTCL entities and their stratification for additional studies and target-directed clinical trials.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/blood.2023021787","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T19:04:59Z","timestamp":1725044699000},"page":"1873-1886","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":32,"title":["New insights into the biology of T-cell lymphomas"],"prefix":"10.1182","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3668-0629","authenticated-orcid":false,"given":"Javeed","family":"Iqbal","sequence":"first","affiliation":[{"name":"1Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-0864","authenticated-orcid":false,"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"2Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[{"name":"3Department of Pathology, City of Hope National Medical Center, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"25","key":"2024103115204503000_bib1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"11","key":"2024103115204503000_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"2024103115204503000_bib3","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017","edition":"4th ed"},{"key":"2024103115204503000_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-62703-170-7_2","volume-title":"T-Cell Lymphomas","author":"Wang","year":"2013"},{"issue":"1","key":"2024103115204503000_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1182\/blood-2011-02-335216","article-title":"Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project","volume":"118","author":"Delabie","year":"2011","journal-title":"Blood"},{"issue":"7","key":"2024103115204503000_bib6","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"18","key":"2024103115204503000_bib7","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath network","volume":"35","author":"Laurent","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2024103115204503000_bib8","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2014-04-573089","article-title":"Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry","volume":"124","author":"Ellin","year":"2014","journal-title":"Blood"},{"issue":"17","key":"2024103115204503000_bib9","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1182\/blood-2013-12-516245","article-title":"How I treat the peripheral T-cell lymphomas","volume":"123","author":"Moskowitz","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2024103115204503000_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.blre.2015.08.003","article-title":"Genomic signatures in T-cell lymphoma: how can these improve precision in diagnosis and inform prognosis?","volume":"30","author":"Iqbal","year":"2016","journal-title":"Blood Rev"},{"issue":"2","key":"2024103115204503000_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.coi.2006.01.006","article-title":"T\u00a0lineage progenitors: the earliest steps en route to T lymphocytes","volume":"18","author":"Wu","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"2024103115204503000_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1323","article-title":"Thymic microenvironments for T cell differentiation and selection","volume":"7","author":"Ladi","year":"2006","journal-title":"Nat Immunol"},{"issue":"2","key":"2024103115204503000_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0092-8674(93)80070-U","article-title":"A\u00a0novel disulfide-linked heterodimer on pre-T cells consists of the T cell receptor beta chain and a 33 kd glycoprotein","volume":"75","author":"Groettrup","year":"1993","journal-title":"Cell"},{"key":"2024103115204503000_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev.immunol.21.120601.141107","article-title":"Positive and negative selection of T cells","volume":"21","author":"Starr","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2024103115204503000_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.immuni.2006.05.010","article-title":"Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation","volume":"25","author":"Ciofani","year":"2006","journal-title":"Immunity"},{"issue":"2","key":"2024103115204503000_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.coi.2009.03.012","article-title":"Transcriptional regulation in helper versus cytotoxic-lineage decision","volume":"21","author":"Taniuchi","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"2024103115204503000_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/intimm\/dxr078","article-title":"Transcriptional control of T-cell development","volume":"23","author":"Naito","year":"2011","journal-title":"Int Immunol"},{"issue":"12","key":"2024103115204503000_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nri1977","article-title":"Structural determinants of T-cell receptor bias in immunity","volume":"6","author":"Turner","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2024103115204503000_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nri3904","article-title":"gammadelta T cells in cancer","volume":"15","author":"Silva-Santos","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2024103115204503000_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2024103115204503000_bib21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ni.3031","article-title":"Molecular regulation of effector and memory T cell differentiation","volume":"15","author":"Chang","year":"2014","journal-title":"Nat Immunol"},{"issue":"5969","key":"2024103115204503000_bib22","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"issue":"5","key":"2024103115204503000_bib23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 costimulation: from mechanism to therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"issue":"9","key":"2024103115204503000_bib24","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-7613(94)80021-9","article-title":"Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors","volume":"1","author":"Linsley","year":"1994","journal-title":"Immunity"},{"issue":"2","key":"2024103115204503000_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"issue":"1","key":"2024103115204503000_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41392-021-00823-w","article-title":"T\u00a0cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"2024103115204503000_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"9","key":"2024103115204503000_bib28","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","article-title":"Application of a 5 marker panel to the routine diagnosis of peripheral T-cell lymphoma with T-follicular helper phenotype","volume":"43","author":"Basha","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2024103115204503000_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000478-200103000-00015","article-title":"Peripheral T-cell lymphoma with follicular involvement and a CD4+\/bcl-6+ phenotype","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2024103115204503000_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"16","key":"2024103115204503000_bib31","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood.2020009004","article-title":"Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study","volume":"137","author":"Falchi","year":"2021","journal-title":"Blood"},{"issue":"6","key":"2024103115204503000_bib32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","article-title":"Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist","volume":"37","author":"Nicolae","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"19","key":"2024103115204503000_bib33","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1182\/bloodadvances.2020002396","article-title":"T\u00a0follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed\/refractory peripheral T-cell lymphoma","volume":"4","author":"Ghione","year":"2020","journal-title":"Blood Adv"},{"issue":"21","key":"2024103115204503000_bib34","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood-2018-04-840538","article-title":"Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma","volume":"132","author":"Lemonnier","year":"2018","journal-title":"Blood"},{"issue":"11","key":"2024103115204503000_bib35","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2024103115204503000_bib36","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"issue":"22","key":"2024103115204503000_bib37","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"issue":"19","key":"2024103115204503000_bib38","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2024103115204503000_bib39","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"issue":"15","key":"2024103115204503000_bib40","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2024103115204503000_bib41","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2024103115204503000_bib42","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"issue":"18","key":"2024103115204503000_bib43","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2014-02-555946","article-title":"The RHOA G17V gene mutation occurs frequently in peripheral T-cell lymphoma and is associated with a characteristic molecular signature","volume":"123","author":"Manso","year":"2014","journal-title":"Blood"},{"issue":"12","key":"2024103115204503000_bib44","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.3324\/haematol.2015.133074","article-title":"A\u00a0highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients","volume":"100","author":"Lee","year":"2015","journal-title":"Haematologica"},{"issue":"11","key":"2024103115204503000_bib45","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"issue":"6127","key":"2024103115204503000_bib46","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1231677","article-title":"(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible","volume":"339","author":"Losman","year":"2013","journal-title":"Science"},{"issue":"9","key":"2024103115204503000_bib47","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A\u00a0targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"issue":"15","key":"2024103115204503000_bib48","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2024103115204503000_bib49","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1038\/bcj.2016.122","article-title":"Identification of cell-type-specific mutations in nodal T-cell lymphomas","volume":"7","author":"Nguyen","year":"2017","journal-title":"Blood Cancer J"},{"issue":"2","key":"2024103115204503000_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/path.4898","article-title":"TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma","volume":"242","author":"Schwartz","year":"2017","journal-title":"J\u00a0Pathol"},{"issue":"10","key":"2024103115204503000_bib51","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1182\/bloodadvances.2020001636","article-title":"Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms","volume":"4","author":"Lewis","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"2024103115204503000_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"4","key":"2024103115204503000_bib53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A\u00a0recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"2024103115204503000_bib54","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1038\/s41467-021-24037-4","article-title":"Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified","volume":"12","author":"Debackere","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"2024103115204503000_bib55","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"issue":"3","key":"2024103115204503000_bib56","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/leu.2017.273","article-title":"Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma","volume":"32","author":"Fujisawa","year":"2018","journal-title":"Leukemia"},{"issue":"8","key":"2024103115204503000_bib57","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1172\/JCI92026","article-title":"Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis","volume":"127","author":"Zang","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"2024103115204503000_bib58","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2017-11-818617","article-title":"RhoA G17V is sufficient to induce autoimmunity and promotes T-cell lymphomagenesis in mice","volume":"132","author":"Ng","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2024103115204503000_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"2024103115204503000_bib60","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.3324\/haematol.2016.147074","article-title":"Comment on: frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma, by Yoo et\u00a0al","volume":"101","author":"Gong","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"2024103115204503000_bib61","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1038\/s41467-021-24037-4","article-title":"Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified","volume":"12","author":"Debackere","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"2024103115204503000_bib62","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s43018-020-00161-w","article-title":"FYN-TRAF3IP2 induces NF-kappaB signaling-driven peripheral T cell lymphoma","volume":"2","author":"Moon","year":"2021","journal-title":"Nat Cancer"},{"issue":"9","key":"2024103115204503000_bib63","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","article-title":"ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma","volume":"37","author":"Attygalle","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2024103115204503000_bib64","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20092042","article-title":"The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma","volume":"207","author":"Pechloff","year":"2010","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"2024103115204503000_bib65","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ccell.2023.01.003","article-title":"IDH2 and TET2 mutations synergize to modulate T follicular helper cell functional interaction with the AITL microenvironment","volume":"41","author":"Leca","year":"2023","journal-title":"Cancer Cell"},{"issue":"12","key":"2024103115204503000_bib66","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.3324\/haematol.2023.282716","article-title":"Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions","volume":"108","author":"Bisig","year":"2023","journal-title":"Haematologica"},{"key":"2024103115204503000_bib67","doi-asserted-by":"crossref","first-page":"1105651","DOI":"10.3389\/fonc.2023.1105651","article-title":"Pathologic and molecular insights in nodal T-follicular helper cell lymphomas","volume":"13","author":"Marques-Piubelli","year":"2023","journal-title":"Front Oncol"},{"issue":"2","key":"2024103115204503000_bib68","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"2024103115204503000_bib69","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.3324\/haematol.2018.213512","article-title":"ALK-positive anaplastic large-cell lymphoma in adults: an individual patient data pooled analysis of 263 patients","volume":"104","author":"Sibon","year":"2019","journal-title":"Haematologica"},{"issue":"12","key":"2024103115204503000_bib70","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"issue":"10","key":"2024103115204503000_bib71","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3324\/haematol.2009.021428","article-title":"Disturbed expression of the T-cell receptor\/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations","volume":"95","author":"Geissinger","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"2024103115204503000_bib72","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"10168","key":"2024103115204503000_bib73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"key":"2024103115204503000_bib74","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/asheducation-2011.1.336","article-title":"Tricky and terrible T-cell tumors: these are thrilling times for testing: molecular pathology of peripheral T-cell lymphomas","volume":"2011","author":"de Leval","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"2024103115204503000_bib75","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2401878","article-title":"Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas","volume":"14","author":"Drexler","year":"2000","journal-title":"Leukemia"},{"issue":"10","key":"2024103115204503000_bib76","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1182\/blood-2014-12-617779","article-title":"Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma","volume":"126","author":"Richly","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2024103115204503000_bib77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1511045","article-title":"Abrupt relapse of ALK-positive lymphoma after discontinuation of crizotinib","volume":"374","author":"Gambacorti-Passerini","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"2024103115204503000_bib78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3324\/haematol.2009.015024","article-title":"Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases","volume":"95","author":"Lamant","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"2024103115204503000_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2024103115204503000_bib80","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1182\/blood-2012-08-447375","article-title":"MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma","volume":"122","author":"Liu","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2024103115204503000_bib81","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3324\/haematol.2013.088286","article-title":"STAT3-mediated activation of microRNA cluster 17\u223c92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma","volume":"99","author":"Spaccarotella","year":"2014","journal-title":"Haematologica"},{"key":"2024103115204503000_bib82","doi-asserted-by":"crossref","first-page":"115747","DOI":"10.1016\/j.bcp.2023.115747","article-title":"MiR-146a-5p enrichment in small-extracellular vesicles of relapsed pediatric ALCL patients promotes macrophages infiltration and differentiation","volume":"215","author":"Garbin","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"702","key":"2024103115204503000_bib83","doi-asserted-by":"crossref","first-page":"eabo3826","DOI":"10.1126\/scitranslmed.abo3826","article-title":"Targeting CCR7-PI3Kgamma overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma","volume":"15","author":"Mastini","year":"2023","journal-title":"Sci Transl Med"},{"key":"2024103115204503000_bib84","doi-asserted-by":"crossref","first-page":"10087","DOI":"10.1038\/ncomms10087","article-title":"Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress","volume":"7","author":"Malcolm","year":"2016","journal-title":"Nat Commun"},{"issue":"9","key":"2024103115204503000_bib85","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms","volume":"28","author":"Piva","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"2024103115204503000_bib86","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells","volume":"178","author":"Mathur","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"26","key":"2024103115204503000_bib87","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1182\/blood-2011-05-354654","article-title":"miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma","volume":"118","author":"Matsuyama","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2024103115204503000_bib88","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/nm.2966","article-title":"PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas","volume":"18","author":"Laimer","year":"2012","journal-title":"Nat Med"},{"issue":"9","key":"2024103115204503000_bib89","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/s41375-018-0045-9","article-title":"The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17\/ILC3 skewing of anaplastic large cell lymphoma","volume":"32","author":"Schleussner","year":"2018","journal-title":"Leukemia"},{"issue":"11","key":"2024103115204503000_bib90","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1038\/leu.2015.127","article-title":"Constitutive control of AKT1 gene expression by JUNB\/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism","volume":"29","author":"Atsaves","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"2024103115204503000_bib91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward\u2013report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"issue":"3","key":"2024103115204503000_bib92","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2010-08-303305","article-title":"Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing","volume":"117","author":"Feldman","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2024103115204503000_bib93","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2024103115204503000_bib94","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2024103115204503000_bib95","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1182\/blood.2019004164","article-title":"\"Double-hit\" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative","volume":"135","author":"Karube","year":"2020","journal-title":"Blood"},{"issue":"6","key":"2024103115204503000_bib96","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3324\/haematol.2022.281442","article-title":"ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study","volume":"108","author":"Sibon","year":"2023","journal-title":"Haematologica"},{"issue":"1","key":"2024103115204503000_bib97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The biology and management of systemic anaplastic large cell lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2024103115204503000_bib98","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3324\/haematol.2022.282025","article-title":"DUSP22-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome","volume":"108","author":"Savage","year":"2023","journal-title":"Haematologica"},{"issue":"3","key":"2024103115204503000_bib99","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"issue":"6","key":"2024103115204503000_bib100","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3324\/haematol.2022.281222","article-title":"DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma","volume":"108","author":"Qiu","year":"2023","journal-title":"Haematologica"},{"issue":"2","key":"2024103115204503000_bib101","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1182\/blood-2014-12-614503","article-title":"Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts","volume":"127","author":"Scarfo","year":"2016","journal-title":"Blood"},{"issue":"26","key":"2024103115204503000_bib102","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2024103115204503000_bib103","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"issue":"15","key":"2024103115204503000_bib104","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1182\/blood-2013-04-497933","article-title":"PRDM1\/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma","volume":"122","author":"Boi","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2024103115204503000_bib105","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","article-title":"CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features","volume":"98","author":"Bisig","year":"2013","journal-title":"Haematologica"},{"issue":"6","key":"2024103115204503000_bib106","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"issue":"36","key":"2024103115204503000_bib107","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.21.02707","article-title":"Gene expression signatures for the accurate diagnosis of peripheral T-cell lymphoma entities in the routine clinical practice","volume":"40","author":"Amador","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"2024103115204503000_bib108","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/leu.2014.347","article-title":"A\u00a0novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation","volume":"29","author":"Abate","year":"2015","journal-title":"Leukemia"},{"issue":"13","key":"2024103115204503000_bib109","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"issue":"2","key":"2024103115204503000_bib110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/tropej\/fmx039","article-title":"Early onset of HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) and adult T-cell leukemia\/lymphoma (ATL): systematic search and review","volume":"64","author":"Oliveira","year":"2018","journal-title":"J\u00a0Trop Pediatr"},{"issue":"3","key":"2024103115204503000_bib111","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"issue":"12","key":"2024103115204503000_bib112","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/sj.leu.2403965","article-title":"FOXP3, a selective marker for a subset of adult T-cell leukaemia\/lymphoma","volume":"19","author":"Roncador","year":"2005","journal-title":"Leukemia"},{"issue":"31","key":"2024103115204503000_bib113","doi-asserted-by":"crossref","first-page":"31991","DOI":"10.1074\/jbc.R400009200","article-title":"Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation","volume":"279","author":"Jeang","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"14","key":"2024103115204503000_bib114","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1182\/blood-2015-08-662593","article-title":"Polycomb-dependent epigenetic landscape in adult T-cell leukemia","volume":"127","author":"Fujikawa","year":"2016","journal-title":"Blood"},{"key":"2024103115204503000_bib115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fmicb.2012.00334","article-title":"Molecular hallmarks of adult T cell leukemia","volume":"3","author":"Yamagishi","year":"2012","journal-title":"Front Microbiol"},{"issue":"11","key":"2024103115204503000_bib116","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"issue":"17","key":"2024103115204503000_bib117","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1182\/blood.2019001815","article-title":"Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions","volume":"135","author":"Yoshida","year":"2020","journal-title":"Blood"},{"issue":"13","key":"2024103115204503000_bib118","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1084\/jem.20140987","article-title":"Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma","volume":"211","author":"Nakagawa","year":"2014","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"2024103115204503000_bib119","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"2024103115204503000_bib120","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2018-01-824607","article-title":"North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies","volume":"132","author":"Shah","year":"2018","journal-title":"Blood"},{"issue":"7607","key":"2024103115204503000_bib121","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"issue":"2","key":"2024103115204503000_bib122","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/cr.2017.146","article-title":"Integrated genomic analysis identifies deregulated JAK\/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemia","volume":"28","author":"Huang","year":"2018","journal-title":"Cell Res"},{"issue":"9","key":"2024103115204503000_bib123","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/leu.2009.91","article-title":"STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK\/T-cell lymphoma","volume":"23","author":"Coppo","year":"2009","journal-title":"Leukemia"},{"issue":"6","key":"2024103115204503000_bib124","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2024103115204503000_bib125","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"issue":"10","key":"2024103115204503000_bib126","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood.V90.10.4099","article-title":"The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease","volume":"90","author":"Teruya-Feldstein","year":"1997","journal-title":"Blood"},{"issue":"7","key":"2024103115204503000_bib127","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1158\/1078-0432.CCR-14-1216","article-title":"Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma","volume":"21","author":"Kucuk","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2024103115204503000_bib128","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/s41375-022-01623-z","article-title":"Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer\/T-cell lymphoma","volume":"36","author":"Dong","year":"2022","journal-title":"Leukemia"},{"issue":"50","key":"2024103115204503000_bib129","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell malignancies","volume":"108","author":"Kucuk","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2024103115204503000_bib130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J\u00a0Hematol Oncol"},{"issue":"6","key":"2024103115204503000_bib131","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep"},{"issue":"12","key":"2024103115204503000_bib132","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/s41375-020-1000-0","article-title":"Whole-genome sequencing identifies responders to Pembrolizumab in relapse\/refractory natural-killer\/T cell lymphoma","volume":"34","author":"Lim","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"2024103115204503000_bib133","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"issue":"13","key":"2024103115204503000_bib134","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","article-title":"Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study","volume":"108","author":"Dupuis","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2024103115204503000_bib135","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2024103115204503000_bib136","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.2008.07042.x","article-title":"Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma","volume":"141","author":"Nelson","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"2024103115204503000_bib137","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.leu.2405028","article-title":"Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma","volume":"22","author":"Nagel","year":"2008","journal-title":"Leukemia"},{"issue":"10","key":"2024103115204503000_bib138","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2008.191","article-title":"High-resolution analysis of chromosome copy number alterations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified, with single nucleotide polymorphism-typing microarrays","volume":"22","author":"Fujiwara","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"2024103115204503000_bib139","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1309\/PNXUKA1CFJMVGCN1","article-title":"Incidence of TCR and TCL1 gene translocations and isochromosome 7q in peripheral T-cell lymphomas using fluorescence in situ hybridization","volume":"130","author":"Feldman","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"2024103115204503000_bib140","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/gcc.20490","article-title":"PVRL2 is translocated to the TRA@ locus in t(14;19)(q11;q13)-positive peripheral T-cell lymphomas","volume":"46","author":"Almire","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"2024103115204503000_bib141","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-09-3843","article-title":"Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma","volume":"108","author":"Martin-Subero","year":"2006","journal-title":"Blood"},{"issue":"3","key":"2024103115204503000_bib142","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"issue":"6","key":"2024103115204503000_bib143","first-page":"735","article-title":"Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly","volume":"464","author":"Somja","year":"2014","journal-title":"Virchows Arch"},{"issue":"11","key":"2024103115204503000_bib144","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"issue":"12","key":"2024103115204503000_bib145","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"issue":"11","key":"2024103115204503000_bib146","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3324\/haematol.2020.262659","article-title":"CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)","volume":"106","author":"Maura","year":"2021","journal-title":"Haematologica"},{"issue":"1","key":"2024103115204503000_bib147","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/leu.2014.261","article-title":"Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis","volume":"29","author":"Schatz","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"2024103115204503000_bib148","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41379-019-0279-8","article-title":"Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified","volume":"33","author":"Laginestra","year":"2020","journal-title":"Mod Pathol"},{"issue":"3","key":"2024103115204503000_bib149","doi-asserted-by":"crossref","first-page":"110695","DOI":"10.1016\/j.celrep.2022.110695","article-title":"Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma","volume":"39","author":"Cortes","year":"2022","journal-title":"Cell Rep"},{"issue":"4","key":"2024103115204503000_bib150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1073\/pnas.1608839114","article-title":"Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas","volume":"114","author":"Abate","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2024103115204503000_bib151","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2016-03-707141","article-title":"Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma","volume":"128","author":"Boddicker","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2024103115204503000_bib152","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2017.186767","article-title":"RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells","volume":"103","author":"Vallois","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"2024103115204503000_bib153","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","article-title":"Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas","volume":"25","author":"Ballester","year":"2006","journal-title":"Oncogene"},{"issue":"3","key":"2024103115204503000_bib154","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J\u00a0Clin Invest"},{"issue":"6","key":"2024103115204503000_bib155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(05)70213-8","article-title":"Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified","volume":"6","author":"Piccaluga","year":"2005","journal-title":"Lancet Oncol"},{"issue":"22","key":"2024103115204503000_bib156","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","author":"Cuadros","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"2024103115204503000_bib157","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","article-title":"Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas","volume":"19","author":"Martinez-Delgado","year":"2005","journal-title":"Leukemia"},{"issue":"11","key":"2024103115204503000_bib158","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood.2021015019","article-title":"DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS","volume":"140","author":"Herek","year":"2022","journal-title":"Blood"},{"issue":"19","key":"2024103115204503000_bib159","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","article-title":"GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"24","key":"2024103115204503000_bib160","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.2019000779","article-title":"Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry","volume":"134","author":"Amador","year":"2019","journal-title":"Blood"},{"issue":"15","key":"2024103115204503000_bib161","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"issue":"1","key":"2024103115204503000_bib162","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","article-title":"Essential role for nuclear PTEN in maintaining chromosomal integrity","volume":"128","author":"Shen","year":"2007","journal-title":"Cell"},{"issue":"7051","key":"2024103115204503000_bib163","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","article-title":"Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"issue":"5","key":"2024103115204503000_bib164","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.celrep.2014.01.030","article-title":"PTEN C-terminal deletion causes genomic instability and tumor development","volume":"6","author":"Sun","year":"2014","journal-title":"Cell Rep"},{"issue":"5","key":"2024103115204503000_bib165","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1182\/blood-2014-04-571372","article-title":"Suppression of T-cell lymphomagenesis in mice requires PTEN phosphatase activity","volume":"125","author":"Newton","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2024103115204503000_bib166","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/cancers15030703","article-title":"Current state and\u00a0future challenges for PI3K inhibitors in cancer therapy","volume":"15","author":"Sirico","year":"2023","journal-title":"Cancers"},{"key":"2024103115204503000_bib167","first-page":"95","volume-title":"Aggressive Lymphomas","author":"Iqbal","year":"2019"},{"key":"2024103115204503000_bib168","doi-asserted-by":"crossref","first-page":"1202964","DOI":"10.3389\/fonc.2023.1202964","article-title":"How molecular advances may improve the diagnosis and management of PTCL patients","volume":"13","author":"Drieux","year":"2023","journal-title":"Front Oncol"},{"issue":"9","key":"2024103115204503000_bib169","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ctrv.2014.08.001","article-title":"Therapeutic options in relapsed or refractory peripheral T-cell lymphoma","volume":"40","author":"Coiffier","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"2024103115204503000_bib170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ctrv.2017.09.002","article-title":"Peripheral T-cell lymphomas: focusing on novel agents in relapsed and refractory disease","volume":"60","author":"Broccoli","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"2024103115204503000_bib171","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11899-015-0291-0","article-title":"The value and relevance of the T cell lymphoma registries and international collaborations: the Case of COMPLETE and the T-Cell Project","volume":"10","author":"Bellei","year":"2015","journal-title":"Curr Hematol Malig Rep"},{"issue":"6","key":"2024103115204503000_bib172","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAS.0000000000000188","article-title":"Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T\/NK-cell lymphomas. A North American PTCL study group project","volume":"38","author":"Hsi","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"2024103115204503000_bib173","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","article-title":"Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States","volume":"34","author":"Adams","year":"2016","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"2024103115204503000_bib174","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood-2023-180318","article-title":"Patterns of care and impact of initial treatment in peripheral T-cell lymphoma: outcome analysis from the Lymphoma Epidemiology of Outcomes (LEO) and Molecular Epidemiology Resource (MER) Prospective Cohort Study","volume":"142","author":"Ruan","year":"2023","journal-title":"Blood"},{"issue":"suppl 1","key":"2024103115204503000_bib175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood-2023-187254","article-title":"Epidemiology, clinical features and outcomes of peripheral T-cell lymphoma in Latin America","volume":"142","author":"Fischer","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2024103115204503000_bib176","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ajcp\/aqaa201","article-title":"Clinicopathologic features of peripheral T-cell lymphoma in Sub-Saharan Africa","volume":"156","author":"Fitzpatrick","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"2024103115204503000_bib177","doi-asserted-by":"publisher","first-page":"039","DOI":"10.23937\/2643-4571\/1710039","article-title":"Peripheral T-cell lymphomas in Algeria: Results from a multicenter registry study","volume":"5","author":"Belarbi","year":"2022","journal-title":"Int J Rare Dis Disord"},{"issue":"8","key":"2024103115204503000_bib178","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00277-019-03694-y","article-title":"First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients","volume":"98","author":"Janikova","year":"2019","journal-title":"Ann Hematol"},{"key":"2024103115204503000_bib179","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12185-014-1520-3","article-title":"Peripheral T cell lymphoma in Asia","volume":"99","author":"Park","year":"2014","journal-title":"Int J Hematol"},{"issue":"5","key":"2024103115204503000_bib180","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/ijmr.IJMR_1108_16","article-title":"Peripheral T cell lymphoma: clinico-pathological characteristics & outcome from a tertiary care centre in south India","volume":"147","author":"Nemani","year":"2018","journal-title":"Indian J Med Res"},{"key":"2024103115204503000_bib181","doi-asserted-by":"crossref","first-page":"863269","DOI":"10.3389\/fonc.2022.863269","article-title":"Epidemiological characteristics of peripheral T-cell lymphoma: a population-based study","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"2024103115204503000_bib182","first-page":"100126","article-title":"Comprehensive analysis of peripheral T-cell and natural killer\/T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia","volume":"10","author":"Yoon","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"2024103115204503000_bib183","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.18632\/oncotarget.14503","article-title":"The heterogeneous landscape of ALK negative ALCL","volume":"8","author":"Mereu","year":"2017","journal-title":"Oncotarget"},{"issue":"supplement 1","key":"2024103115204503000_bib184","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1182\/blood-2023-186969","article-title":"Gene expression profiling reveals two overarching types of anaplastic large cell lymphoma with distinct targetable biology: An L.L.M.P.P. Study","volume":"142","author":"Feldman","year":"2023","journal-title":"Blood"},{"issue":"12","key":"2024103115204503000_bib185","first-page":"1108","article-title":"Update on recurrent mutations in angioimmunoblastic T-cell lymphoma","volume":"14","author":"Yu","year":"2021","journal-title":"Int J Clin Exp Pathol"},{"issue":"5\u20136","key":"2024103115204503000_bib186","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1615\/CritRevOncog.2017020816","article-title":"Oncogenic signaling pathways and pathway-based therapeutic biomarkers in lymphoid malignancies","volume":"22","author":"Sun","year":"2017","journal-title":"Crit Rev Oncog"},{"issue":"15","key":"2024103115204503000_bib187","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.3390\/cancers14153716","article-title":"Mutations affecting genes in the proximal T-cell receptor signaling pathway in peripheral T-cell lymphoma","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2024103115204503000_bib188","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3390\/ijms18091904","article-title":"Aberrant signaling pathways in T-cell acute lymphoblastic leukemia","volume":"18","author":"Bongiovanni","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2024103115204503000_bib189","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/pbc.24153","article-title":"ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase\/Akt activity with retained but inactivated PTEN--a report from the Children\u2019s Oncology Group","volume":"59","author":"Thakral","year":"2012","journal-title":"Pediatr Blood Cancer"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/18\/1873\/2311687\/blood_bld-2023-021787-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/18\/1873\/2311687\/blood_bld-2023-021787-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T15:21:25Z","timestamp":1730388085000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/18\/1873\/517650\/New-insights-into-the-biology-of-T-cell-lymphomas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":189,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,10,31]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023021787","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}